Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$113.21
-5.7%
$115.63
$96.43
$153.84
$34.11B1.231.86 million shs3.95 million shs
Bruker Corporation stock logo
BRKR
Bruker
$41.96
-2.9%
$39.32
$34.10
$72.94
$6.55B1.181.77 million shs2.18 million shs
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$157.71
-1.5%
$152.34
$134.65
$252.88
$27.70B1.31.66 million shs2.41 million shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$51.42
-2.3%
$50.35
$46.01
$83.62
$8.25B1.391.48 million shs1.53 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-5.73%-6.51%-3.21%+10.13%-13.58%
Bruker Corporation stock logo
BRKR
Bruker
-2.89%-0.94%+9.56%+11.18%-33.83%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
-1.47%-4.24%+0.68%+6.04%-30.18%
Bio-Techne Corp stock logo
TECH
Bio-Techne
-2.28%-2.39%+1.78%+2.90%-33.40%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
4.7718 of 5 stars
3.35.02.53.62.20.81.9
Bruker Corporation stock logo
BRKR
Bruker
4.9782 of 5 stars
4.23.01.73.82.95.01.9
IQVIA Holdings Inc. stock logo
IQV
IQVIA
4.9182 of 5 stars
4.43.00.04.62.81.72.5
Bio-Techne Corp stock logo
TECH
Bio-Techne
4.8693 of 5 stars
4.33.01.74.22.21.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.54
Moderate Buy$139.7723.46% Upside
Bruker Corporation stock logo
BRKR
Bruker
2.40
Hold$52.8926.05% Upside
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.75
Moderate Buy$222.4541.05% Upside
Bio-Techne Corp stock logo
TECH
Bio-Techne
2.50
Moderate Buy$70.0036.13% Upside

Current Analyst Ratings Breakdown

Latest BRKR, TECH, A, and IQV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/11/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Outperform ➝ Sector Outperform$90.00 ➝ $75.00
7/9/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$170.00 ➝ $180.00
7/9/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$65.00
7/8/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$125.00 ➝ $130.00
6/26/2025
Bruker Corporation stock logo
BRKR
Bruker
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$61.00 ➝ $50.00
6/24/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $125.00
6/5/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
5/30/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$135.00
5/30/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$59.00
5/29/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$150.00 ➝ $130.00
5/29/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$160.00 ➝ $155.00
(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.51B4.94$5.89 per share19.21$20.53 per share5.51
Bruker Corporation stock logo
BRKR
Bruker
$3.45B1.85$3.49 per share12.03$11.85 per share3.54
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$15.41B1.77$16.36 per share9.64$33.43 per share4.72
Bio-Techne Corp stock logo
TECH
Bio-Techne
$1.16B6.95$2.26 per share22.74$13.13 per share3.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.29B$4.0527.9518.623.6417.59%25.92%13.24%8/20/2025 (Estimated)
Bruker Corporation stock logo
BRKR
Bruker
$113.10M$0.5280.6913.322.902.31%19.47%5.95%8/5/2025 (Estimated)
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$1.37B$7.3421.4912.931.788.61%29.16%6.96%7/22/2025 (Estimated)
Bio-Techne Corp stock logo
TECH
Bio-Techne
$168.10M$0.8262.7126.102.5010.89%13.17%10.17%8/6/2025 (Estimated)

Latest BRKR, TECH, A, and IQV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q4 2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.49N/AN/AN/A$315.14 millionN/A
8/5/2025Q2 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.43N/AN/AN/A$811.17 millionN/A
7/22/2025Q2 2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$2.76N/AN/AN/A$3.96 billionN/A
5/28/2025Q2 2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.26$1.31+$0.05$0.75$1.63 billion$1.67 billion
5/7/2025Q1 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.46$0.47+$0.01$0.11$763.83 million$801.40 million
5/7/2025Q3 2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.51$0.56+$0.05$0.14$317.92 million$316.18 million
5/6/2025Q1 2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$2.63$2.70+$0.07$1.40$3.77 billion$3.83 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.990.87%N/A24.44%9 Years
Bruker Corporation stock logo
BRKR
Bruker
$0.200.48%N/A38.46%N/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
N/AN/AN/AN/AN/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.320.62%N/A39.02%N/A

Latest BRKR, TECH, A, and IQV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.24800.9%7/1/20257/1/20257/23/2025
5/12/2025
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.5%6/16/20256/16/20256/27/2025
5/19/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.080.67%5/19/20255/19/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.55
2.09
1.60
Bruker Corporation stock logo
BRKR
Bruker
1.13
1.57
0.74
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.19
0.82
0.82
Bio-Techne Corp stock logo
TECH
Bio-Techne
0.16
3.71
2.58

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bruker Corporation stock logo
BRKR
Bruker
79.52%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
89.62%
Bio-Techne Corp stock logo
TECH
Bio-Techne
98.95%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bruker Corporation stock logo
BRKR
Bruker
27.30%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
1.60%
Bio-Techne Corp stock logo
TECH
Bio-Techne
3.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
17,900284.07 millionN/AOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,396151.53 million110.16 millionOptionable
IQVIA Holdings Inc. stock logo
IQV
IQVIA
88,000173.00 million170.23 millionOptionable
Bio-Techne Corp stock logo
TECH
Bio-Techne
3,100156.77 million150.65 millionOptionable

Recent News About These Companies

Analysts Set Bio-Techne Corp (NASDAQ:TECH) PT at $70.00
Scotiabank Cuts Bio-Techne (NASDAQ:TECH) Price Target to $75.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$113.21 -6.87 (-5.72%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$113.17 -0.04 (-0.04%)
As of 07/15/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Bruker stock logo

Bruker NASDAQ:BRKR

$41.96 -1.25 (-2.89%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$42.01 +0.05 (+0.12%)
As of 07/15/2025 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

IQVIA stock logo

IQVIA NYSE:IQV

$157.71 -2.42 (-1.51%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$157.74 +0.03 (+0.02%)
As of 07/15/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$51.42 -1.20 (-2.28%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$51.64 +0.21 (+0.42%)
As of 07/15/2025 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.